The average payout for a defective hip replacement class action typically ranges from $50,000 to $600,000 per plaintiff, depending on the manufacturer involved, the severity of injury, and whether revision surgery was required. Across all major cases, hip replacement manufacturers have paid more than $7 billion in total settlements over the years, with some individual verdicts reaching into the hundreds of millions. For example, DePuy signaled willingness to pay roughly $300,000 per patient in individual cases tied to its ASR and Pinnacle hip systems, while Stryker’s settlement structure allowed individual plaintiffs to receive up to $600,000.
These figures come from years of litigation against manufacturers like DePuy (Johnson & Johnson), Stryker, Zimmer Biomet, Wright Medical, and Exactech. As of February 2026, 2,054 hip cases out of 33,450 filed remain pending nationwide, meaning that while the bulk of litigation has resolved, thousands of plaintiffs are still waiting on outcomes.
Table of Contents
- How Much Do Defective Hip Replacement Lawsuits Pay on Average?
- DePuy ASR and Pinnacle Settlements — The Largest Hip Implant Payouts
- Stryker’s $2.2 Billion in Hip Implant Settlements
- How Zimmer Biomet and Wright Medical Settlements Compare
- The Exactech Litigation — What Pending Cases Mean for Future Payouts
- What Factors Push a Hip Replacement Settlement Higher or Lower
- What the Future Holds for Hip Implant Litigation
- Frequently Asked Questions
How Much Do Defective Hip Replacement Lawsuits Pay on Average?
The short answer is that there is no single average, because settlement amounts vary dramatically by manufacturer and case specifics. At the low end, Zimmer Biomet’s 2016 Durom Cup settlement established a base award of $175,000 per hip. At the high end, Stryker’s Rejuvenate and ABG II settlement allowed individual payouts of up to $600,000. DePuy’s approach landed somewhere in the middle, with roughly $300,000 per patient as a benchmark figure across its ASR and Pinnacle cases. These numbers represent negotiated settlement amounts, not jury verdicts. Verdicts can be significantly higher.
A jury awarded $502 million to just five plaintiffs in a DePuy Pinnacle hip implant trial, which works out to roughly $100 million per plaintiff before any post-trial reductions. Manufacturers typically settle to avoid that kind of exposure, which is why the negotiated per-plaintiff figures are substantially lower. It is also worth noting that settlement amounts are usually paid before attorney fees and litigation costs are deducted, so the net amount a plaintiff takes home is typically 60 to 70 percent of the gross settlement figure. The variation within any given settlement is driven by individual factors. Someone who needed one revision surgery and recovered well will receive less than someone who endured multiple surgeries, developed metallosis from metal-on-metal debris, or suffered permanent disability. Settlement grids used in mass tort cases assign point values to these factors, and the final payout depends on where a plaintiff falls on that grid.
DePuy ASR and Pinnacle Settlements — The Largest Hip Implant Payouts
DePuy, a subsidiary of Johnson & Johnson, has been responsible for the largest share of hip implant settlement dollars. The company’s ASR Hip System was recalled in 2010 after data showed unacceptably high failure rates. In 2013, DePuy agreed to pay $4 billion to settle more than 8,000 lawsuits related to the ASR system. That figure made it one of the largest medical device settlements in history at the time. The Pinnacle Hip Implant followed a similar trajectory. J&J agreed to pay $1 billion in 2019 to resolve up to 95 percent of approximately 6,000 pending Pinnacle lawsuits.
The Pinnacle cases were notable for producing enormous jury verdicts before settlement, including the $502 million award to five plaintiffs that put pressure on the company to negotiate. However, if you filed a Pinnacle claim after the 2019 settlement deadline or did not meet the qualifying criteria, your case may not have been included in that resolution, and remaining claims face a more uncertain path. One important limitation: these settlement totals do not mean every plaintiff received an equal share. The $4 billion ASR fund divided among 8,000-plus claimants does not simply yield $500,000 each. Administrative costs, attorney fees held in common benefit funds, and the tiered payout structure based on injury severity all reduce the per-person amount. Plaintiffs with the most serious injuries received the most, while those with fewer complications received less.
Stryker’s $2.2 Billion in Hip Implant Settlements
Stryker paid nearly $2.2 billion total in hip implant settlements, making it the second-largest payer in this space after DePuy. The bulk of that figure came from a December 2014 offer of $1.425 billion to settle more than 5,000 lawsuits involving its Rejuvenate and ABG II hip systems. Both devices were recalled in 2012 after reports of corrosion and fretting at the neck-stem junction, which released metal debris into surrounding tissue. The Stryker settlement was structured to allow individual plaintiffs to receive up to $600,000 in damages, which represents the high end of what any single manufacturer has offered per plaintiff in a hip implant mass tort. That ceiling applied to the most severely injured claimants — those who required revision surgery, experienced significant metal contamination, or suffered lasting disability.
The base amounts for less severe cases were lower, though specific tier breakdowns were not made fully public. What made the Stryker litigation distinct was the speed of resolution relative to other hip implant cases. The recall happened in 2012, and a major settlement was on the table by late 2014. That relatively quick turnaround was partly because the failure mechanism was well-documented and hard for Stryker to dispute. For plaintiffs, the lesson is that cases with clear-cut defects and strong causation evidence tend to resolve faster and at higher per-plaintiff amounts than cases where the defect or injury link is more contested.
How Zimmer Biomet and Wright Medical Settlements Compare
Zimmer Biomet and Wright Medical settled their respective hip implant cases for smaller total amounts than DePuy or Stryker, though the per-plaintiff figures were still significant. In 2016, Zimmer settled hundreds of Durom Cup lawsuits at a base award of $175,000 per hip, totaling $314 million. Earlier, in 2010, Zimmer Biomet had set up a $47.5 million settlement fund for faulty hip implants, and Biomet separately reached a $56 million settlement over defective hip replacements before the two companies merged. Wright Medical paid $330 million to settle complaints related to its Conserve, Dynasty, and Lineage hip implant products. Like the Stryker cases, these involved metal-on-metal designs that shed debris into patients’ bodies.
The per-plaintiff breakdown for Wright Medical settlements was not publicly detailed in the same way as DePuy or Stryker, but the total divided among the number of claimants suggests individual payouts in a range roughly comparable to the Zimmer Durom Cup base figure. The tradeoff for plaintiffs in these smaller settlements is worth understanding. Zimmer’s $175,000 base award was lower than the DePuy or Stryker benchmarks, but it came with less litigation risk and faster resolution for many claimants. Going to trial against a manufacturer can yield a much larger verdict, but it also carries the risk of losing entirely and receiving nothing. Many plaintiffs, particularly older individuals dealing with ongoing health issues, chose the certainty of a settlement over the uncertainty of a trial.
The Exactech Litigation — What Pending Cases Mean for Future Payouts
The most significant active hip implant litigation as of early 2026 involves Exactech. There are 1,838 lawsuits pending in a multidistrict litigation (MDL), and the case is complicated by the fact that Exactech filed for Chapter 11 bankruptcy, temporarily halting all lawsuits. The company also paid $8 million to resolve False Claims Act allegations from the U.S. government, which accused Exactech of knowingly selling defective implants — a fact that could strengthen individual plaintiffs’ cases if litigation resumes. Projected individual settlement amounts for Exactech cases range from $50,000 to $300,000 or more, though this remains highly uncertain pending the bankruptcy resolution.
Four bellwether trial cases have been selected, which will be among the first to go to trial and will help establish the value of the broader pool of cases. Until those trials produce verdicts or lead to settlement negotiations, any payout estimate is speculative. The bankruptcy filing is the major wildcard. If Exactech’s bankruptcy plan caps its total liability or channels claims through a trust with limited funding, plaintiffs could receive substantially less than they would in a direct settlement with a solvent manufacturer. This is a real risk, and anyone with a pending Exactech claim should be following the bankruptcy proceedings closely. The situation is fundamentally different from the DePuy or Stryker cases, where the parent companies had deep pockets and chose to settle rather than face continued litigation.
What Factors Push a Hip Replacement Settlement Higher or Lower
The single biggest factor in determining individual payout is whether the plaintiff required revision surgery — a second operation to remove and replace the defective implant. Revision surgeries are major procedures with longer recovery times and higher complication rates than the original surgery, and they consistently command higher settlement values across all manufacturers. Cases involving chronic pain, metallosis (metal poisoning from implant debris), bone loss, or permanent mobility limitations also settle at the higher end of the range.
Age and overall health matter as well, though in a more detailed way. A younger plaintiff who will live with the consequences of a defective implant for decades may have a stronger damages claim than an older plaintiff, but older plaintiffs who experienced surgical complications or prolonged hospitalization can also receive substantial awards. The strength of medical documentation linking the plaintiff’s specific injuries to the defective implant, rather than to pre-existing conditions or normal aging, is often the deciding factor in where a case falls on the settlement grid.
What the Future Holds for Hip Implant Litigation
With more than 2,000 hip cases still pending nationwide and the Exactech MDL in a holding pattern due to bankruptcy, hip implant litigation is far from over. The bellwether trials selected in the Exactech case will be closely watched by both plaintiffs’ attorneys and manufacturers, as their outcomes will set expectations for the remaining cases. If verdicts come in high, Exactech or its bankruptcy trust will face pressure to offer meaningful settlements.
If verdicts are mixed or favor the defense, plaintiffs may see lower offers or longer waits. Looking beyond Exactech, the hip implant litigation landscape has matured to the point where manufacturers take recall and defect claims seriously, in large part because of the $7 billion-plus that has already been paid out. Future cases involving new implant designs or materials will benefit from the legal precedents and settlement frameworks established in the DePuy, Stryker, and Zimmer litigations. For anyone currently dealing with a failed hip implant, the historical record shows that legitimate claims do get compensated, but patience and strong medical documentation are essential.
Frequently Asked Questions
How long does it take to receive a hip replacement settlement payout?
Most plaintiffs wait two to five years from the time they file a lawsuit to the time they receive payment. The DePuy ASR cases took roughly three years from recall to settlement agreement, while the Stryker Rejuvenate cases resolved in about two years. However, cases involving bankruptcy, like Exactech, can take significantly longer due to court proceedings that must resolve before any payments are distributed.
Do I need to have had revision surgery to file a claim?
Not necessarily, but revision surgery is the strongest evidence of a defective implant and significantly increases the value of a claim. Plaintiffs who experienced pain, metallosis, or other complications without revision surgery have still received settlements, though typically at lower amounts. The key is documented medical evidence that links your symptoms to the implant defect.
Will my settlement be taxable?
Generally, settlement compensation for physical injuries or illness is not taxable under federal law. However, any portion allocated to punitive damages or interest is typically taxable. Consult a tax professional, because the specific tax treatment depends on how the settlement is structured and what categories of damages are included.
What if my hip implant manufacturer went bankrupt?
Bankruptcy does not eliminate your claim, but it changes how and when you get paid. In the Exactech case, the Chapter 11 filing created an automatic stay that temporarily halts all lawsuits. Claims are typically channeled through a bankruptcy trust, and payouts depend on the trust’s total funding. Plaintiffs in bankruptcy cases often receive less than they would in a direct settlement with a solvent company.
Can I still file a hip replacement lawsuit in 2026?
It depends on your state’s statute of limitations and when you discovered (or should have discovered) the defect. Many states have a two- to three-year window from the date of injury or discovery. With 2,054 cases still pending as of February 2026, litigation remains active, but filing deadlines vary. An attorney can evaluate whether your claim is still timely.
What is metallosis and why does it affect settlement amounts?
Metallosis is a condition caused by metal debris from metal-on-metal hip implants accumulating in the tissue surrounding the joint. It can cause chronic pain, tissue death, bone loss, and systemic metal poisoning. Cases involving metallosis tend to settle at the higher end of the range because the condition often requires revision surgery, causes lasting damage, and is directly attributable to the defective implant design.
You Might Also Like
- What Is the Average Timeline for a Medical Device Class Action
- What Is the Average Settlement for a Medical Device Class Action
- How to Join a Class Action for Defective Artificial Joints